A Closer Look At AstraZeneca plc

As Pfizer attempts a £60bn takeover of AstraZeneca (LSE: AZN) (NYSE: AZN.US), two Fools take a closer look at the pharmaceutical company in the investing video…

If you own shares in AstraZeneca and are looking for other high-yielders outside the sector, then check out this free wealth report from The Motley Fool, which identifies five names that should provide you with a comfortable, stress-free retirement. Just click here for details, with no obligations!

Neither Nate nor Mark own shares in AstraZeneca.